Ellevest Inc’s Allogene Therapeutics ALLO Stock Holding History

Ellevest Inc’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-33	Closed	-$1K	–	1114
2020 Q1	$1K	Buy	+33	New	+$786	﹤0.01%	832

Other funds holding ALLO

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return

Ellevest Inc's ALLO Position: Q2 2020 in Review

Ellevest Inc sold out of Allogene Therapeutics (ALLO) in Q2 2020, closing a stake of 33 shares — an estimated $1K sold.

Ellevest Inc first reported a position in ALLO in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 173 funds tracked by Wall St. Rank hold ALLO as of Q2 2020.

Ellevest Inc reported no remaining Allogene Therapeutics position as of Q2 2020 after selling out during the quarter.
Ellevest Inc sold 33 Allogene Therapeutics shares in Q2 2020, an estimated $1K.
Ellevest Inc first reported a position in Allogene Therapeutics in Q1 2020 and held it in 1 quarter.
Ellevest Inc's Allogene Therapeutics position peaked at $1K in Q1 2020.
173 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2020.

Based on Ellevest Inc's 13F filing for Q2 2020, filed 6 Jul 2020.